期刊
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
卷 12, 期 1, 页码 410-428出版社
MDPI AG
DOI: 10.3390/ijms12010410
关键词
ovarian cancer; autoantibodies; immunoproteomics
资金
- Ovarian Cancer Research Foundation (OCRF), Melbourne, Australia
Most scientific efforts towards early detection of ovarian cancer are commonly focused on the discovery of tumour-associated antigens (TAA). Autologous antibodies against TAA, however, may serve as more sensitive diagnostic markers. They circulate in the blood before TAA and are usually more abundant than the TAAs themselves as a result of amplification through the humoral immune response. Accumulating evidence also suggests that a humoral response already exists during malignant transformation when aberrant gene expression is translated into premalignant cellular changes. This article reviews the current knowledge about autoantibodies against TAA in ovarian cancer and presents current immunoproteomic approaches for their detection.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据